I think it’s horses for courses. Some products we will run with fully natural and some synthesis’s CBD etc.
Some treatments may be combos of a natural drug with an already approved traditional drug. I don’t think we will limit ourselves.
I do think it likely we will probably be trying to get a couple of the products the new acquisition has in its quiver ramped up in the market for some early revenue flow.
I expect some sort of video interview in the next week or two perhaps and other media that will elaborate a bit more detail on this deal
Those nervous about the seemingly lowish purchase price of our new company... ask yourself this, would you be happier paying tenfold? No!
Buffet made a career, a fortune from buying undervalued companies with potential and building them.
These guys know exactly what they are buying and what represents good value.
- Forums
- ASX - By Stock
- IHL
- Ann: Incannex to Acquire APIRx Pharmaceuticals
Ann: Incannex to Acquire APIRx Pharmaceuticals, page-99
-
-
- There are more pages in this discussion • 362 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online